𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas

✍ Scribed by J. S. Lewis; R. J. Landers; J. C. E. Underwood; A. L. Harris; C. E. Lewis


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
418 KB
Volume
192
Category
Article
ISSN
0022-3417

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Vascular permeability factor (Vascular e
✍ Anthony J. Guidi; Stuart J. Schnitt; Lars Fischer; Kathi Tognazzi; Jay R. Harris πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 387 KB

histologic features on hematoxylin and eosin stained sections, and microvessel density and distribution using sections immunostained for factor VIII-related anti-1 Departments of Pathology, Beth Israel Deagen. In addition, in situ hybridization was performed on formalin fixed, paraffin coness Medica

Biologic implications of the expression
✍ Jiro Fujimoto; Hideki Sakaguchi; Reiko Hirose; Satoshi Ichigo; Teruhiko Tamaya πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 123 KB πŸ‘ 1 views

## BACKGROUND. Vascular endothelial growth factor (VEGF) has been identified as an important factor for tumor angiogenesis, which is essential for the growth, invasion, and metastasis of solid tumors. This study examines the clinical significance of VEGF subtypes in ovarian carcinoma. ## METHODS.

Prognosis of breast-carcinoma lymphagene
✍ Jocelyne Jacquemier; Marie-Pierre Mathoulin-Portier; Reija Valtola; Emmanuelle C πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 336 KB

Very few studies have yet addressed the question of the existence and role of lymphagenesis in tumor growth; it is generally overshadowed by the greater emphasis placed on the blood vascular system. Monoclonal antibodies against vascular endothelial-growth-factor receptor 3 (VEGFR3) have been shown